Yashica Pharmaceuticals Private Limited
Thane, Maharashtra
GST 27AAACY3217A1ZT
TrustSeal Verified
IndiaMART Verified Exporter
Approx. Rs 500 / Pack
Cefuroxime injection is used to treat certain infections caused by bacteria including pneumonia and other lower respiratory tract (lung) infections; meningitis (infection of the membranes that surround the brain and spinal cord); gonorrhea (a sexually transmitted disease); and skin, blood, bone, joint, and urinary tract infections. Cefuroxime injection may also be used before, during, and sometimes for a brief period after surgery in order to prevent the patient from getting an infection. Cefuroxime injection is in a class of medications called cephalosporin antibiotics. It works by killing bacteria.
Antibiotics such as cefuroxime injection will not work for colds, flu, or other viral infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Approx. Rs 100 / box
TEST | SPECIFICATION |
Description | A white coloured, oblong shaped, biconvex film coated tablet with break-line on one side. |
Identification (HPLC):
| Should comply The principal peak obtained in the chromatogram of test solution should correspond to the peak obtained in the chromatogram of reference solution. |
Average Weight of 20 Tablets | 755.00 mg ± 5% |
Uniformity of weight | Within ± 5% of average weight |
Height | 16.60 mm ± 0.1 mm |
Thickness | 5.80 mm ± 0.2 mm |
Disintegration Time | NMT 30 min in water at 37℃ |
Dissolution | NLT 80% (Q) |
Assay: | 90.0% to 110.0% |
Approx. Rs 18 / BOX
Approx. Rs 100 / Strip of 6 Tablets
NAME OF PRODUCT : YASHIAZEE (Azithromycin Tablets 250 mg) | |
TEST | SPECIFICATION AS PER USP |
Description | A white coloured, round shaped, biconvex, film coated tablet plain on both side. |
Identification (HPLC) | Should comply as pr IHS The retention time of the major peaks in the chromatogram of the assay preparation should correspond to that with the chromatogram of std preparations as obtained in the assay. |
Average Weight | 42745 mg ± 3% |
Uniformity of weight | within ± 5% of average weight |
Disintegration Time | NMT 30 min in water medium at 37? |
Friability | NMT 1.0% |
Assay - Each film coated tablet contains: Azithromycin Dihydrate eq to Azithromycin Base………250 mg | 90.0% to 110.0% |
Approx. Rs 250 / BOX
TEST | SPECIFICATION AS PER BP |
Description | A yellow coloured, oblong shaped, biconvex film coated tablet. |
Identification: 1. By IR |
Should comply |
Average Weight of 20 Tablets | 1009.41 mg ± 3% |
Uniformity of weight | Within ± 5% of average weight |
Height | 20.10 mm ± 0.2 mm |
Thickness | 6.10 mm ± 0.2 mm |
Disintegration Time | NMT 30 min in water at 37℃ |
Dissolution | NLT 70% (Q) |
Uniformity of Content | 85% to 115% |
Assay (HPLC): | 95.0% to 105.0% |
Related Substances | Should comply as per BP |
Approx. Rs 150 / Pack
Composition: |
|
CATEGORY : |
|
PHARMACODYNAMICS : |
|
PHARMACOKINETICS : |
|
Approx. Rs 150 / Pack
TEST | SPECIFICATION AS PER USP |
Description | A red coloured, round shaped, convex, film coated tablet, plain on both sides. |
Identification: 1. By IR
2. By TLC
| A) IR- The infrared absorbtion spectrum of the residue should be concordant with the reference spectrum. B) Shake a quantity of the powdered tablets containing 0.2 g of Metronidazole with 4 mL of 0.5M sulfuric acid and filter. To the filtrate add 10 mL of picric acid solution R1 and allow standing. The melting point of the precipitate should be measured. C) Heat a quantity of the powdered tablets containing 10 mg of Metronidazole on a water bath with 10 mg of zinc powder, 1 mL of water and 0.25 mL of hydrochloric acid for 5 minutes, cool in ice, add 0.5 mL of sodium nitrite solution and remove the excess of nitrite with sulfamic acid. Add 0.5 mL of 2-naphthol solution and 2 mL of 5M sodium hydroxide. |
Avg. Wt. Of 20 Tablets | 462 mg ± 3.0% |
Uniformity of Net Weight | Within ± 5% of average weight |
Diameter | 11.2 mm ( ± 0.1mm ) |
Thickness | 4.7 mm ( ± 0.1mm ) |
Disintegration Time | NMT 30 min in water at 37°C |
Related Substances: | The area of any secondary peak in chromatogram obtained with solution (2) should not be greater than area of the peak due to 2-methyl-5-nitroimidazole in the chromatogram obtained with solution (1). |
Dissolution | NLT 85% (Q) |
Assay: Each film coated tablet contain: Metronidazole USP 250 mg |
95% to 105% |
Approx. Rs 200 / box
TEST | SPECIFICATION AS PER BP |
Description | A Black / Orange colored, size "2" hard gelatin capsules containing white coloured Powder. |
Identification: 1. By IR
2. By TLC
| Should comply as per BP The infrared absorption spectrum obtained with test should be concordant with the reference spectrum of amoxicillin trihydrate. The principal spot in the chromatogram obtained with test solution should similar in position, colour and size to that in the chromatogram obtained with reference solution . |
Average Net Content of 20 Capsules | 290.00 mg ± 7.5% |
Uniformity of Net Weight | Within ± 10% of average weight |
Disintegration Time | NMT 30 min in water at 37°C |
Related Substances: | Should comply as per BP |
Total Impurity | In the chromatogram obtained with test solution: The area of any secondary peak should not greater than the area of the principal peak in the chromatogram obtained with test solution (2) (1%). |
Assay: Each Hard Gelatin Capsule Contains : Amoxycilline Trihydrate BP Eq.to Amoxicillin anhydrous...................250 mg |
92.5% TO 110% |
Approx. Rs 150 / Vial
Approx. Rs 50 / Strip
TEST | SPECIFICATION |
Description | A white coloured, round shaped, biconvex, film-coated tablet, bisected on one side & plain on other side. |
Identification By HPLC
| Should comply as per USP The RT of the major peak for cefixime in the chromatogram of the assay preparation should correspond to that in the chromatogram of the standard preparation as obtained in the assay. |
Thickness | 4.20 mm ± 0.2 mm |
Diameter | 9.60 mm ± 0.2 mm |
Average Weight | 312.73 mg ± 3.0% |
Uniformity of weight | within ± 5.0% of average weight |
Water | NMT 10.00% |
Disintegration Time | NMT 30 minutes |
Dissolution | NLT 75.0% (Q) |
Assay - Each film-coated tablet contains: Cefixime USP eq to anhydrous Cefixime 200 mg | 90.0% to 110.0% of Label claim |
Approx. Rs 250 / Vial
TESTS | SPECIFICATION |
Description | A white to off white powder, highly hygroscopic |
Identification By liquid chromatography | The retention time of principal peaks in the sample solution should correspond to the retention time of principal peaks in the chromatogram obtained with standard solution. |
pH | Between 5.0 to 7.0 |
Organic Impurities |
|
Tazobactam related compound A | NMT 1.0% |
Piperacillin impurity 4 | NMT 1.0% |
Piperacillin impurity 1 | NMT 1.0% |
Piperacillin impurity A | NMT 5.0% |
Piperacillin impurity C | NMT 1.0% |
Piperacillin impurity 5 | NMT 1.0% |
Piperacillin impurity 6 | NMT 1.0% |
Any individual unspecified impurity | NMT 1.0% |
Total impurities | NMT 5.0 % |
Water | NMT : 2.5 % w/w |
Sterility | Should be sterile |
Bacterial Endotoxins | Not more than 0.08 EU in a portion of equi. to 1 mg of a mixture of piperacillin and tazobactam |
Particulate matter |
|
i) Visual | Should be free from visible particles |
ii) Light Obscuration |
|
a) ≥ 10 µ b) ≥ 25 µ | Not more than 6000/g Not more than 600/g |
Constituted solution (Completeness and clarity of solution) | a) The solid should dissolve completely, leaving no visible residue as undissolved matter. b) The constituted solution should not be significantly less clear than an equal volume of the diluents or purified water contained in similar vessel and examined similarly. |
Assay 1. Piperacillin Sodium eq. to Piperacillin 2. Tazobactam Sodium eq. to Tazobactam |
Limit :72.0 % to 88.0 % Limit : 9.0 % to 11.0 % |
Approx. Rs 50 / Strip of 10 Tablets
We are leading manufacturer and exporter of Doxycycline Capsules and our product is made up of good quality.
Our company is able to gain appreciation and recognition in the medical industry in offering clinically tested array of Yashicycline Capsules-insert and it contain doxycycline hyclate, a broad spectrum antibiotic synthetically derived from oxytetracycline.
It is used in the treatment of bacterial infections by controlling the growth of bacteria. The capsules are offered in 100 mg strength capacity.
TEST | SPECIFICATION AS PER BP |
Description | A pink/pink coloured, size 2, hard gelatin capsule containing yellow powder. |
Identification: 1. By TLC
2. By Colour Development
3. Reaction of Chlorides | Should comply as per BP 1. The principal spot in the chromatogram obtained with test solution should be similar in position, colour and size to that with the chromatogram obtained with standard solution. 2. A yellow colour should be produced by adding Sulfuric acid. 3. Should comply as per BP |
Average Net Content | 267.00 mg ± 7.5% |
Uniformity of weight | within ± 10% of average weight |
Disintegration Time | NMT 30 min |
Loss on Drying | NMT 8.5% (at 105??? for 2h for 1g) |
Related Substances | Should comply as per BP |
Light Absorbing Impurities | Absorbance of the filtrate at 490 nm should not be more than 0.20, calculated with reference to dried capsule content. |
Assay - Each hard gelatin capsule contains: Doxycycline Hydrochloride BP: 100 mg |
95.0% to 105.0% (95.0 mg - 105.0 mg) |
Approx. Rs 12,000 / Kg
Approx. Rs 75 / Stripe
Aciclovir is an antiviral drug. It slows the growth and spread of the herpes virus in the body. It will not cure herpes, but it can lessen the symptoms of the infection.
Aciclovir is used to treat infections caused by herpes viruses, such as genital herpes, cold sores, shingles, and chicken pox.
Aciclovir may also be used for purposes not listed in this medication guide.
TEST | Limits |
Description | White coloured round shaped, flat bevelled edged, uncoated tableted bisected on one end. |
Identification | Mus comply as per BP |
Average Weight | 307.50 mg ± 5% |
Uniformity of Weight | ± 5.0% of average weight |
Thickness | 3.50 ± 0.20 mm |
Friability | NMT 1.0 % |
Diameter | 9.50 mm ± 0.20 mm |
Hardness | NLT 3.0 kg / cm2 |
Dissolution | NLT 70 % |
Related Substances | Mus comply as per BP |
Guanine | Mus comply as per BP |
Disintegration Time | NMT 15 min in Purified Water |
Assay | 95.0% to 105.0% |
Approx. Rs 150 / Pack
TEST | SPECIFICATION AS PER BP |
Description | An off-white coloured, oblong shaped, biconvex uncoated tablet bisected on one side. |
Identification: 1. By IR
2. By TLC
| Should comply as per BP 1a. IR of Sulfamethoxazole: The IR spectrum of test should be concordant with reference spectrum of Sulfamethoxazole. 1b. IR of Trimethoprim: The IR spectrum of test should be concordant with reference spectrum of Trimethoprim. 2. One of the principal spots obtained in the chromatogram with solution 1 should correspond with the chromatogram spot obtained with solution 2 and the other spot should correspond with the chromatogram spot obtained with solution 3. |
Average Weight of 20 Tablets | 1050.00 mg ± 5% |
Uniformity of weight | Within ± 5.0% of average weight |
Diameter | 20.00 mm ± 0.2 mm |
Thickness | 5.90 mm ± 0.2 mm |
Disintegration Time | NMT 15 min in water at 37℃ |
Friability | NMT 1.0% |
Hardness | NLT 3 Kg/cm2 |
Assay: Each uncoated tablet - Suphamethoxazole BP 800 mg Trimethoprim BP 160 mg | 92.5% to 107.5% 740.0 mg - 860.0 mg 148.0 mg - 172.0 mg |
Approx. Rs 75 / Pack
NAME OF PRODUCT : Clarithromycin Syrup | |
TEST | SPECIFICATION AS PER USP |
Test | In-House Specification |
Description | A White To Light Pink Coloured Strawberry Flavored Granular Powder. |
Identification | Must Complies As Per USP The Retention Time Of The Major Peak Of The Sample Solution Corresponds To That Of The Standard Solution As Obtained In The Assay. |
PH | 4.0 – 5.4 |
Net Filled Volume | 10.0 Gm/60 ML |
Wt. Per Ml | About 1 Gm/Ml |
Loss On Drying | NMT 2.0 % |
Assay | Each 5 Ml Of Reconstituted Suspension Contains Clarithromycin USP……..125 Mg LIMIT: 90.0 % To 115.0% After 7 Days Clarithromycin USP……125 Mg LIMIT: 90.0 % To 115.0% |
Approx. Rs 50 / Strip
NAME OF PRODUCT : Ciprofloxacin Tablets | |
TEST | SPECIFICATION AS PER USP |
TEST | SPECIFICATION |
Description | A White Coloured, Oblong Shaped, Biconvex Film Coated Tablet With Break-Line On One Side. |
Identification (HPLC): | Should Comply As Per USP The Principal Peak Obtained In The Chromatogram Of Test Solution Should Correspond To The Peak Obtained In The Chromatogram Of Reference Solution. |
Average Weight Of 20 Tablets | 755.00 Mg ± 5% |
Uniformity Of Weight | Within ± 5% Of Average Weight |
Height | 16.60 Mm ± 0.1 Mm |
Thickness | 5.80 Mm ± 0.2 Mm |
Disintegration Time | NMT 30 Min In Water At 37? |
Dissolution | NLT 80% (Q) |
Assay: Each Film Coated Tablet Contains: Ciprofloxacin Hydrochloride USP Eq. To Ciprofloxacin 500mg | 90.0% To 110.0% 450 Mg To 550 Mg |
Approx. Rs 100 / Pack
NAME OF PRODUCT : YASHICILLIN 500 (Ampicillin Capsules BP 500 mg) | |
TEST | SPECIFICATION AS PER USP |
Description | A maroon/yellow coloured size 0 hard gelatin capsule containing white coloured powder. |
Identification: | Should comply as per BP |
1. By Colour Development 2. By TLC | A magenta-violet colour should be produced immediately. The principal spot in the chromatogram obtained with test casolution should be similar in position, colour and size with that of the chromatogram obtained with reference solution. |
Average Net Content of 20 Capsules | 571.00 mg ± 3.0% |
Uniformity of Net Weight | Within ± 7.5% of average weight |
Disintegration Time | NMT 30 min in water at 37? |
Related Substances: | Should comply as per BP |
Total Impurity | In the chromatogram obtained with test solution: the area of any secondary peak should not be greater than the area of the principal peak in the chromatogram obtained with test solution (2) (1%) |
Assay: Each capsule contains: Ampicillin Trihydrate BP eq. to Ampicillin anhydrous 500mg | 92.50% to 107.50% 462.50 mg to 537.50 mg |
We will contact you soon !
Sanjay Totre
(Managing Director)
Yashica Pharmaceuticals Private Limited
Syndicate, Thane,
Maharashtra,
India